tropacine has been researched along with Basal Ganglia Diseases in 2 studies
*Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SAVENKO, SN; SOLOV'EVA, NS | 1 |
| OVECHKIN, VR; SHEFER, DG; ZYKOVA, AT | 1 |
2 other study(ies) available for tropacine and Basal Ganglia Diseases
| Article | Year |
|---|---|
[Tropacine therapy of extrapyramidal syndrome].
Topics: Acetates; Basal Ganglia Diseases; Disease; Extrapyramidal Tracts; Tropanes | 1955 |
[Therapy of diseases of the central nervous system with extrapyramidal disorders with tropacin].
Topics: Acetates; Basal Ganglia Diseases; Disease; Extrapyramidal Tracts; Humans; Tropanes | 1954 |